Transcript Highlights:

• you know, COVID brought us into a new awareness of the risks and problems with blind trust in pharmaceutical
• manufacturer can be held responsible when their defective product causes harm. harm someone, why not the pharmaceutical
• but for far too many, that trust was betrayed, not by their neighbors or their doctors, but by pharmaceutical
• Why should pharmaceutical companies be any different?
• That's the—so the federal, the— The federal law that gave pharmaceuticals the no liability was not so

Bills: HB220, HB783, HB2240, HB3336, HB4202, HB4449, HB4904, HB3441, HB4284

Keywords: sexual assault, healthcare facilities, forensic examination, survivor support, emergency contraceptive, online impersonation, civil liability, social media, identity theft, defamation, counseling damages, injunctive relief, public health, safety regulations, community health, state standards, healthcare access, HB 3336, alcoholic beverage tax credit, spent grain

Transcript Highlights:

• you know, COVID brought us into a new awareness of the risk and problems with blind trust in pharmaceutical
• manufacturer can be held responsible when their defective product harms someone, why not the pharmaceutical
• but for far too many that trust was betrayed, not by their neighbors or their doctors, but by pharmaceutical
• Why should pharmaceutical companies be any different?
• That's, that's the attempt anyway, that's so The federal law that Gave pharmaceuticals the the no liability

Bills: HB 220, HB 783, HB 2240, HB 3336, HB 4202, HB 4449, HB 4904, HB 3441, HB 4284

Keywords: sexual assault, healthcare facilities, forensic examination, survivor support, emergency contraceptive, online impersonation, civil liability, social media, identity theft, defamation, counseling damages, injunctive relief, public health, safety regulations, community health, state standards, healthcare access, HB 3336, alcoholic beverage tax credit, spent grain

Transcript Highlights:

• It didn't come from pharmaceutical companies. They are not involved with this.
• </c> It didn't come from pharmaceutical It didn't come from pharmaceutical companies.<00:35:44.040><c
• , in licensing and sale of pharmaceuticals.
• ,</c> in the development of pharmaceuticals, in the development of pharmaceuticals, in<00:45:21.000><
• And we also have these pharmaceuticals.

Keywords: 981, all

Summary: The Senate met with a quorum, approved the journal, and then proceeded out of order to consider Senate Joint Resolution 20, recognizing April 9, 2026, as Home Education Day in Colorado. Senator Pelton spoke in strong support of home education, describing it as a parent-led choice that benefits students and families. The resolution was adopted on a 30-0 vote, and the current roll was added as co-sponsors. The chamber then took up the consent calendar and passed House Bill 1229, House Bill 1244, and Senate Bill 153. HB 1229, which concerns the human-animal bond as a social determinant of health, drew three no votes from Senators Pelton, Zamora Wilson, and Baeza; the other two measures passed unanimously. The Senate also laid over third reading of bills until Friday, April 10. In Committee of the Whole, senators considered Senate Bill 72, which increases criminal penalties for assaultive conduct involving a motor vehicle and adds causing death with a motor vehicle to criminally negligent homicide. The committee adopted the report and advanced the bill on second reading. Later, the chamber laid over Senate Bill 134 and House Bill 1084 until April 10, and then took up Senate Bill 140, which would exempt certain rare disease and plasma therapies from review by the Prescription Drug Affordability Review Board. Sponsors and supporters argued the bill protects access for patients with rare diseases and prevents harm to treatment development, while opponents said it would weaken the PDAB’s affordability work and was too broad. Senators Weisman and Gonzales spoke against the bill, with Weisman citing concerns about the federal definition used and Gonzales defending the PDAB’s role in lowering drug costs; the debate continued in the transcript without a final vote shown.

Transcript Highlights:

• I would challenge the pharmaceutical industry to find a single player that makes claims anything close
• You may hear a lot of rhetoric from the for-profit trillion-dollar pharmaceutical companies that are
• companies that are busy pharmaceutical companies that are busy spending<00:26:12.880><c> millions</c
• Pharmaceutical company that is out of state, counting up their dough, make up your mind for you.
• go up for patients pharmaceuticals go up for patients because<00:32:26.159><c> the</c><00:32:26.399>

Keywords: 919, house, all

Summary: House File 369 was the main topic, with House authors Rep. Natalie Zeleznikar, Rep. Robert Bierman, and Rep. Dave Baker arguing that the bill would give Minnesota’s 2024 340B law “teeth” by enforcing protections for nonprofit and rural hospitals’ access to the federal drug pricing program. They said the measure costs the state nothing, aligns with similar laws in more than 20 other states, and is needed before adjournment to help hospitals close funding gaps, support services like emergency care, obstetrics, behavioral health, and pharmacy access, and preserve care in remote communities. Several hospital leaders from across greater Minnesota testified that 340B revenue helps keep their facilities viable and that losing it would threaten services and, in some cases, hospital survival. Witnesses described severe financial pressure on rural hospitals, including reimbursement cuts, workforce shortages, inflation, and rising drug costs. Leaders from United Hospital District in Blue Earth, Lakewood Health System in Staples, Ely-Bloomenson Community Hospital, Northshore Health in Grand Marais, Community Memorial Hospital in Cloquet, and Cuyuna Regional Medical Center in Crosby said their hospitals serve as safety-net providers and often operate with thin or negative margins. They emphasized long travel times to other hospitals, seasonal tourism pressures in some areas, and the importance of local emergency, ambulance, inpatient, and specialty services. The Minnesota Hospital Association president also criticized pharmaceutical company messaging and said nonprofit hospitals are working around the clock to maintain access. In response to questions, Zeleznikar said she had considered other enforcement approaches but now supported using the original Senate-passed bill, citing concerns about fraud and the difficulty of alternative enforcement mechanisms. She and hospital leaders distinguished this bill from a separate hospital stabilization-grant proposal, saying both are needed but serve different purposes. No vote was taken at the meeting, and the speakers repeatedly urged House leadership to bring the bill to the floor before session ends.

Transcript Highlights:

• These are not pharmaceutical companies setting up money aside to pay medical bills.
• The plan, not just 10% that are using 80% of the pharmaceutical coverage.
• The plan, not just 10% that are using 80% of the pharmaceutical coverage.
• pharmaceutical companies.
• First of all, I'm here representing both Pfizer-N-Vartis pharmaceutical companies, so very large pharmaceutical

Summary: The committee first heard House Bills 2365, 2490, and 2249, a bipartisan version of Elijah’s Law, which would require child care facilities to receive training and guidance on recognizing and responding to food allergies and anaphylaxis. Sponsors described the bill as a response to the death of Elijah, whose daycare did not administer epinephrine quickly enough after a food exposure. Witnesses in support, including a parent and food allergy advocate, said the measure would improve preparedness and save lives. Committee members asked about whether the bill should use broader epinephrine terminology, whether the requirements could also be handled through child care licensing rules, and whether the bill was already included in a larger measure. No opposition was presented, and the hearing on those bills was closed. The committee then heard House Bill 1965, which would require insurers to reimburse athletic trainers for covered services and add athletic trainers to the practitioner definition for billing purposes. The sponsor and athletic training witnesses said the bill would recognize athletic trainers as licensed health care providers, improve access in rural and underserved areas, and allow reimbursement when trainers work in clinics, hospitals, or other non-school settings. Committee members raised repeated questions about the difference between athletic trainers and physical therapists, whether school-based services were already paid through contracts, whether the bill would increase costs or create double payment, and how diagnosis and billing would work under the current scope of practice. Opponents from Blue Cross and Blue Shield of Kansas City and the Missouri Insurance Coalition argued the bill would create a mandate, increase costs, and expand billing before clarifying the underlying scope of practice. No vote was taken in public hearing. The committee then moved into executive session and voted several bills do pass. A substitute was adopted for House Bill 1826 and the committee substitute for House Bills 1826, 2560, 2349, and 2194 passed 17-0. House Bill 1783 also passed 17-0. House Bill 2372, which incorporated multiple related provisions including changes to epinephrine terminology and other committee items, passed 17-1 after a substitute and amendment were adopted. House Bill 1827, the occupational therapy bill related to disabled placards and license plates, passed 18-0. The committee then returned to public hearing and heard House Bills 1941 and 2279, which would prohibit copay accumulator programs for fully insured plans so that third-party assistance counts toward a patient’s deductible and out-of-pocket maximum. Sponsors and a rheumatologist testified that the bills would prevent patients with serious illnesses from being forced to pay the same deductible twice and said similar laws have been enacted in many other states. Opponents from America’s Health Insurance Plans argued the measure would affect only a minority of plans, raise costs in the individual and small-group market, and could worsen affordability for remaining enrollees. The hearing ended without a vote on those bills.

Transcript Highlights:

• This bill applies skilled and trained workforce standards to pharmaceutical facilities.
• It actually applies skilled and trained workforce standards to pharmaceutical facilities.
• Pharmaceutical facilities are not typical construction projects.
• The reliability of domestic pharmaceutical manufacturing is critical.
• We appreciate the author's intent to ensure quality and safety in the construction of pharmaceutical

Summary: The committee heard several labor and workforce bills. SB 1059 would modernize the Employment Training Panel by allowing electronic record-keeping, digital attendance documentation, and updated training terminology; supporters said it would reduce paperwork and better match current training systems, while no opposition appeared. SB 966 would codify refinery process safety protections adopted in 2017 after the 2012 Chevron Richmond fire, including worker participation in safety proceedings, anonymous hazard reporting, access to safety information, and stop-work authority; labor supported it, while the Western States Petroleum Association opposed it as conflicting with a 2024 settlement and potentially preempted by federal labor law. SB 1024 would provide 26 weeks of paid postpartum and recovery leave for firefighters who give birth, with job restoration and no requirement to use sick or vacation time first; firefighters and labor groups strongly supported it, and the committee discussed staffing and operational coverage concerns, but no opposition testified. The committee also heard SB 1316, which would strengthen wage theft enforcement by allowing Labor Commissioner liens to be renewed, limiting employers’ late use of records, and requiring Cal/OSHA to report complaints and citations data annually. Supporters said the bill would help workers actually collect wages after long delays and prevent employers from hiding records; it passed the committee on a 5-0 vote. SB 1185 would apply skilled and trained workforce requirements to pharmaceutical facility construction and maintenance, with supporters arguing these facilities require high precision to protect public health and supply chains; construction industry opponents said the bill was an unnecessary expansion of state mandates into private projects. SB 1227 would create apprenticeship pathways into DIR enforcement jobs, including Cal/OSHA and Labor Commissioner roles, to address staffing shortages and improve labor law enforcement; supporters emphasized vacancies and backlogs, and the bill was framed as a way to build a merit-based pipeline into state service. After hearing testimony, the committee took final votes on all six bills once the full membership returned. SB 966, SB 1024, SB 1059, SB 1185, and SB 1227 were all reported out of committee, and SB 1316 was also passed and sent to the Senate Judiciary Committee. The recorded final votes were unanimous or near-unanimous in favor, with the bills advancing on 4-1 or 5-0 votes depending on the measure.

Transcript Highlights:

• This bill applies skilled and trained workforce standards to pharmaceutical facilities.
• It actually applies skilled and trained workforce standards to pharmaceutical facilities.
• Pharmaceutical facilities are not typical construction projects.
• We appreciate the author's intent to ensure quality and safety in the construction of pharmaceutical
• We appreciate the author's intent to ensure quality and safety in the construction of pharmaceutical

Summary: The committee heard and later voted on six labor-related bills. SB 1059 would modernize the Employment Training Panel by allowing electronic record-keeping, digital attendance documentation, and updated training terminology; supporters said it would reduce paperwork and better match current workforce training practices, while no opposition appeared. SB 966 would make permanent 2017 refinery process safety protections, including worker participation in safety reviews and stop-work authority; refinery workers and unions supported it as a safeguard against rollback, while the Western States Petroleum Association opposed it, arguing it conflicted with a settlement and could be preempted by federal labor law. SB 1024 would provide 26 weeks of paid postpartum and recovery leave for firefighters who give birth and require return to the prior position; supporters said it would improve retention and equity in a male-dominated profession, and there was no opposition. The committee also heard SB 1316, which would strengthen wage theft and workplace safety enforcement by allowing renewal of labor commissioner liens, limiting employers’ late use of records, and requiring Cal/OSHA to report complaints and citations data annually. Supporters said the bill would help workers collect judgments and address long backlogs; there was no opposition, and the bill passed 4-0 on call before the full committee vote. SB 1185 would apply skilled-and-trained workforce requirements to pharmaceutical facility construction and maintenance; supporters from the building trades said these projects require specialized precision to protect public health and supply chains, while contractors opposed the bill as an unnecessary expansion of public-work-style mandates into private projects. Finally, SB 1227 would create apprenticeship pathways into Department of Industrial Relations enforcement jobs, including Cal/OSHA and the Labor Commissioner’s office, to address staffing shortages and backlogs. The author and supporters said apprenticeships could help fill vacancies while preserving the civil service merit principle and creating opportunities for displaced workers; there was no opposition. After discussion and roll calls, the committee reported all six bills out of committee, with SB 966, SB 1024, SB 1059, SB 1185, and SB 1227 sent to Appropriations, and SB 1316 sent to Judiciary.

Transcript Highlights:

• Because kratom's active compounds vary in strength from product to product, the dose a person receives
• Kratom's<00:42:59.440><c> two</c><00:42:59.840><c> main</c><00:43:00.120><c> compounds,</c><00:43:00.760
• ><c> mitragynine</c> Kratom's two main compounds, mitragynine Kratom's two main compounds, mitragynine
• Because<00:43:12.480><c> kratom's</c><00:43:12.960><c> active</c><00:43:13.280><c> compounds</c><00:43
• :13.840><c> vary</c> Because kratom's active compounds vary Because kratom's active compounds vary in

Bills: HF3771, HF3658, HF3453, HF3358, HF1775

Keywords: disaster assistance, contingency account, Minnesota emergency management, public safety, state disaster aid, FEMA, federal cost-share, emergency relief, natural disaster, budget report, appropriations report, management and budget, local governments, utility cooperatives, public works, infrastructure repair, chapter 12B, chapter 12A, emergency management, disaster recovery

Transcript Highlights:

• There's a pharmaceutical component to this bill as well. Can you elaborate on that, please?
• But, yeah, pharmaceuticals are things that are also available right here in Missouri.
• But, yeah, pharmaceuticals are things that are also available right here in Missouri.
• But, yeah, pharmaceuticals are things that are also available right here in Missouri.
• I, however, do not want to give tax incentives to pharmaceutical companies.

Summary: The Commerce Committee met with quorum and first took up several bills in executive session. It adopted a House committee substitute for House Bill 2080 and then voted the substitute do pass on a 6-2 roll call. The committee also voted House Bill 1745 do pass by 6-2 and House Bill 3230 do pass unanimously, 8-0. HB 2080 was described as a proposal related to state investment in cryptocurrency, including Bitcoin, other crypto and stablecoins, with a trigger tied to constitutional changes and language allowing staking of assets. In public hearing, House Bill 3490, sponsored by Rep. Mike Jones, would modify Missouri’s Local Historic Preservation Act so that in certain large cities, property owned by public or private colleges and universities could not be designated as historic landmarks by local commissions. Supporters argued the bill would protect property rights and allow universities to develop campus property, while opponents and some members said it appeared aimed at a specific Kansas City dispute and could be overbroad or an overreach into local historic preservation. No one testified in formal support or opposition, and the hearing closed without action. The committee then heard House Bill 3316, a Department of Revenue cleanup bill sponsored by Rep. Jeff Knight. The department said it would simplify vehicle registration and titling, including flat registration fees instead of horsepower-based fees, changes to alternative fuel decals, disabled placards, Real ID document retention, out-of-state vehicle tax collection, legal-name titling, higher late-registration penalties, and ending even-odd year registration. Members asked about water-damaged titles, dealer plate thresholds, emissions inspections, and temporary tags; the department and sponsor said they were open to amendments on some points. Copart testified in informational support, asking that resale exemptions remain intact. The committee then heard House Bill 3027, also by Rep. Knight, which would create tax incentives for companies producing critical minerals, materials, and certain pharmaceuticals in Missouri. The sponsor and supporters said the bill was aimed at reducing dependence on foreign supply chains and encouraging mining and processing in-state; a chemical manufacturer suggested tightening the bill by making credits nontransferable and tying them to actual production and profitability, and the Missouri Chamber supported the concept. After the hearings, the committee adjourned.

Transcript Highlights:

• These are the three agencies that control pharmaceutical waste in Minnesota, and there are no compliance
• Man, I just had a question on what's the volume of dollars of pharmaceuticals that you have sent out
• So, uh, and you mentioned at the start $16 million of potential pharmaceuticals that go into the waste
• of pharmaceuticals that you have<00:15:51.199><c> sent</c><00:15:51.440><c> out</c><00:15:51.680><c>
• that go into potential pharmaceuticals that go into waste<00:16:09.360><c> stream.

Bills: HF3475, SF3832, HF3508, HF3917, HF3404, HF3593

Keywords: agriculture, education, leadership council, compensation, research institute, dairy assistance, investment relief, agriculture support, food production, economic relief, investment, relief initiative, farm support, medication repository, drug donation, healthcare, Minnesota Statutes, pharmacy, public health, controlled substances

Transcript Highlights:

• Purdue Pharmaceuticals are going to have billions of dollars in fines and settlements really coming up
• Purdue Pharmaceuticals,<00:04:49.520><c> Purdue</c><00:04:49.919><c> Pharmaceuticals</c> Pharmaceuticals
• , Purdue Pharmaceuticals Pharmaceuticals, Purdue Pharmaceuticals are<00:04:50.880><c> going</c><00:04
• And what we have to do, members, is we have to have our claims bar released so that when pharmaceutical
• Pharmaceutical companies agree to give us the money that is owed to us so that we can get it to our communities

Keywords: 1183, house

Transcript Highlights:

• 00:35:27.599><c> Veterinary</c> continuation of the Veterinary continuation of the Veterinary Pharmaceutical
• Advisory</c><00:35:29.200><c> Committee</c><00:35:29.359><c> and</c><00:35:29.599><c> in</c> Pharmaceutical
• Advisory Committee and in Pharmaceutical Advisory Committee and in connection<00:35:30.000><c> therewith
• Regulatory Agencies to repeal the Regulatory Agencies to repeal the Veterinary<00:35:36.720><c> Pharmaceutical
• </c><00:35:37.359><c> Advisory</c> Veterinary Pharmaceutical Advisory Veterinary Pharmaceutical Advisory

Keywords: 981, all

Transcript Highlights:

• I think the pharmaceuticals, The pharmaceutical companies are rightly concerned that, you know, they
• When it started in the 1990s, it was at the impetus of the pharmaceutical companies themselves.
• But pharmaceutical companies point to another set of court cases that show that Ability to regulate here
• But pharmaceutical companies point to another set of court cases that show no, states really can't regulate
• And we also want to make sure that we're not punishing pharmaceutical companies and making it difficult

Keywords: 904, all

Summary: Senate and House Republican leaders held a joint media availability focused on affordability, budget concerns, and opposition to several Democratic tax proposals. John Braun and Drew Stokesbary said Washingtonians are still struggling with the cost of food, gas, housing, child care, and health care, and argued Democrats are not advancing bills that would ease those pressures. They criticized a draft income tax proposal they said would function as a small business tax, especially because it would disallow loss carryforwards and could discourage investment in housing and other capital-intensive sectors. They also objected to a proposed tire fee and a bill they said would prevent tire sellers from telling customers about the tax. The Republicans said they planned to raise budget and tax concerns in an upcoming meeting with Governor Ferguson, and Stokesbary said he had introduced a budget-savings bill to consolidate University of Washington investment management with the State Investment Board. They also discussed a bill to make it harder to qualify citizen initiatives, calling it anti-democratic, and said they want stronger oversight and legal reforms related to DCYF and state liability in child welfare cases. Braun and Stokesbary said they were open to discussing tort reform and a civil claims process, but emphasized the underlying problem is state failure in protecting children. On health care, they said they were still reviewing a bill to eliminate interest on medical debt and a separate 340B drug-pricing proposal, warning both could have unintended effects on hospitals, patients, and drug innovation. They also said they support the idea of protecting children online and in schools, but want any social media, AI chatbot, or cell phone-related bills written carefully to avoid First Amendment problems and unintended consequences. On public safety, they expressed concern about a bill restricting police retention of automatic license plate reader data, arguing law enforcement needs such tools to solve crimes. No votes were taken, and the event ended with the Republicans reiterating their opposition to tax increases and their focus on affordability.

Transcript Highlights:

• Phil Chris Finnelli with the Pharmaceutical Care Management Association.
• They negotiate discounts with large pharmaceutical manufacturers.
• They negotiate discounts with large pharmaceutical manufacturers.
• It will result in higher drug prices, it will result in more pharmaceutical manufacturer profits, and
• Ultimately, drug prices are set by the pharmaceutical manufacturer.

Summary: The House Insurance Committee met on April 1 with a quorum present and first took up House Bill 938 by Rep. Turner, which would overhaul pharmacy benefit manager (PBM) regulation by setting a flat administration fee, requiring dispensing fees and NADAC-based reimbursement, mandating rebate pass-through, giving the Department of Insurance access to PBM data, and creating a reverse-auction process for PBM procurement. Turner said the bill is intended to level the playing field for independent pharmacies, improve transparency, and reduce hidden PBM practices. The committee adopted amendment set 1444 without objection, and Turner said additional conceptual amendments were still being worked on. Supporters included independent pharmacies and the PBM Accountability Project; opponents included union plan representatives, benefits consultants, and PBM/insurance industry witnesses who warned of higher costs, ERISA preemption problems, and likely litigation. After extended questioning on cost, preemption, and vertical integration, the committee reported HB 938 with amendments. The committee then considered House Bill 870, also by Rep. Turner, dealing with formulary placement and cost-sharing for generic drugs and biosimilars and limiting certain utilization management practices. Amendment set 1540 was adopted, revising and tightening technical definitions. Turner and a representative of the Association for Accessible Medicines argued the bill would help lower-cost generics and biosimilars gain market share and reduce patient costs, citing examples such as insulin and Humira biosimilars. Opponents from Louisiana Blue said the bill would force coverage based on wholesale acquisition cost rather than net cost, would raise premiums for fully insured members, and would mandate coverage of drugs that are not always the lowest net-cost option. Rep. Jordan again raised ERISA and preemption concerns, and committee members discussed whether the bill would interfere with tiering and plan design. After closing comments and a motion by Rep. Glorioso, HB 870 was reported with amendments, and the committee adjourned.

Transcript Highlights:

• started up around 7 or 8 years ago because they found it within the marketplace, especially in most pharmaceuticals

Bills: SB1423, SB1426, SB1502, SB1377, SB1983, SB1466, SB1645, SB1647, SB1847, SB1565, SB1562, SB1329, SB1383, SB1833, SB1555, SB1344

Keywords: Oklahoma Hospital Advisory Council, hospital licensure, public health, State Department of Health, State Board of Health, hospital regulations, healthcare regulation, hospital standards, hospital construction, hospital operations, stroke care, stroke system, emergency medical services, EMS transport, psychiatric treatment, chemical dependency treatment, substance use disorder, drug storage, pharmacy, quality indicators

Transcript Highlights:

• around seven or eight years ago because they found it within the marketplace, especially in most pharmaceuticals

Bills: SB1423, SB1426, SB1502, SB1377, SB1983, SB1466, SB1645, SB1647, SB1847, SB1565, SB1562, SB1329, SB1383, SB1833, SB1555, SB1344

Keywords: Oklahoma Hospital Advisory Council, hospital licensure, public health, State Department of Health, State Board of Health, hospital regulations, healthcare regulation, hospital standards, hospital construction, hospital operations, stroke care, stroke system, emergency medical services, EMS transport, psychiatric treatment, chemical dependency treatment, substance use disorder, drug storage, pharmacy, quality indicators

Summary: The Health and Human Services committee met and advanced a series of Senate bills, beginning with SB 1423, which repeals the Hospital Advisory Council because of repeated quorum and appointment problems; members discussed whether the council could instead be restructured, but the bill passed 9-1. SB 1426 changed vulnerable adult abuse reporting so only substantiated findings are reported, and SB 1502 repealed the Long-Term Care Advisory Council after it completed its original task; both passed unanimously. The committee also approved SB 1377 to provide duffel bags for children entering foster care and SB 1983 to support resource family partners and improve foster care/adoption outcomes, both by unanimous votes. Members then passed SB 1466, which extends the sunset on the advisory committee on midwifery after adopting an amendment changing the extension date; SB 1645, which sets rules and best practices for OHCA audits of medical providers; SB 1647, which allows up to $1 million from the County Community Safety Investment Fund to support evidence-based pretrial diversion programs through the Indigent Defense System; and SB 1847, which lets certain Advantage Waiver Medicaid recipients with cognitive impairment remain in assisted living and age in place. The committee also approved SB 1565, establishing the framework for Oklahoma to receive federal Transforming Maternal Health Model grant funds, after adding a reporting amendment requiring a final report to state leaders. Additional bills passed included SB 1562, described as an anti-poaching measure for hospice patients that holds hospices responsible for contractor conduct; SB 1329, requiring postpartum mental health screening during Medicaid-covered visits within a year after birth; SB 1383, a technical cleanup to the diabetes self-management education program; SB 1833, directing DHS to apply for a SNAP waiver to restrict certain purchases such as candy and soft drinks; and SB 1555, updating the statutory definition of intellectual disability to align with federal and Social Security standards. The final measure, SB 1344, created an insulin access and affordability program at the State Department of Health to expand low-cost insulin access and competition; it drew discussion about funding, pricing, and the nonprofit partner involved, and passed 9-2. The committee adjourned after the chair noted more double-assigned bills would be heard the following week.

Transcript Highlights:

• So, I would agree that there are some situations regarding pharmaceuticals.

Bills: SB128, SB640, SB672, SB904, SB1141, SB1263, SB1525, SB1528, SB2041, SB2306, SB2308, SB2357, SB2446, SB2695, SB2857, SB2891, SB2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, SB 640, Texas Family Code, Department of Family and Protective Services, DFPS, child welfare, foster care, managing conservatorship, suicide attempt, youth suicide, mental health, child protective services, state custody, annual report, reporting requirements

Transcript Highlights:

• It allows Louisiana to join a consortium of other states working with pharmaceutical companies to get
• relative to peptides, regulation of peptides by licensing boards, and requirements for providers in compounding

Bills: HR252, HR253, HR254, HR255, HR256, HCR103, HCR104, HR244, HR245, HR246, HR247, HR248, HR249, HR250, HR251, HCR101, HCR102, SCR40, SCR60, SB112, SB131, SB145, SB194, SB268, SB307, SB312, SB319, SB333, SB341, SB346, SB464, SB466, SB488, SB495, SB503, SB507, SB509, HR9, HR196, HCR27, HCR28, HCR50, HCR62, HCR67, HCR71, HCR78, HCR81, SCR20, HB123, HB251, HB625, HB662, HB709, HB769, HB775, HB783, HB895, HB1011, HB1057, HB1155, HB1186, HB1224, HB1245, HB1247, HB1253, HB1254, HB1255, HB1256, SB8, SB10, SB11, SB12, SB13, SB14, SB16, SB17, SB18, SB20, SB21, SB22, SB40, SB48, SB55, SB69, SB75, SB77, SB78, SB85, SB102, SB115, SB133, SB140, SB148, SB151, SB165, SB169, SB170, SB185, SB197, SB200, SB217, SB235, SB278, SB280, SB291, SB300, SB303, SB315, SB324, SB330, SB411, SB416, SB420, SB436, SB438, SB449, SB455, SB456, SB477, SB489, SB521, SB97, SB105, HR171, HCR49, HCR65, HCR72, HR37, HCR64, HR170, HR191, HR206, HR207, HR208, HR217, HCR11, HCR53, HCR60, HCR66, HCR68, SCR19, SCR3, SCR6, SCR18, SCR11, SCR22, SCR2, HCR6, HB64, HB68, HB92, HB130, HB258, HB633, HB801, HB61, HB98, HB102, HB139, HB142, HB170, HB185, HB194, HB199, HB231, HB247, HB294, HB336, HB474, HB661, HB842, HB852, HB66, HB153, HB165, HB326, HB387, HB455, HB513, HB603, HB660, HB719, HB762, HB766, HB802, HB816, HB833, HB940, HB950, HB975, HB1028, HB1039, HB1051, HB1053, HB1080, HB1201, HB1215, HB1228, HB1251, HB1252, SB1, SB23, SB32, SB42, SB43, SB46, SB51, SB110, SB113, SB150, SB154, SB161, SB218, SB220, SB221, SB253, SB289, SB310, SB351, SB399, SB404, SB502, SB26, SB28, SB29, SB30, SB41, SB44, SB64, SB84, SB87, SB93, SB98, SB107, SB118, SB142, SB192, SB195, SB199, SB219, SB222, SB234, SB241, SB255, SB275, SB277, SB292, SB294, SB306, SB314, SB482, HCR32, HB798, HB998, HB1084, HB1223, HB59, HB955, HB1191, HB1234, HB646, HB824, HB341, SB397, SB442, HB901, HB79, HR20, HR74, HB284, HB306, HB366, HB393, HB458, HB577, HB582, HB605, HB614, HB682, HB733, HB752, HB773, HB911, HB926, HB996, HB1035, HB1069, HB1113, HB1140, HB1180, HB1240, SB47, SB82, SB89, SB149, SB382

Keywords: consumer protection, credit card fees, cash transactions, rounding practices, transparency, low-income, economic impact, residential construction, building codes, inspection practices, housing costs, task force, HR254, House Resolution 254, Ty Hebert, Acadiana Legislative Delegation, Louisiana State University, LSU, graduation, commendation

Transcript Highlights:

• This bill costs the state nothing, and it is supported by the Pharmaceutical Association.
• somebody has maybe a learning disability or is autistic or has some sort of health condition that just compounds

Keywords: 959, house, all

Transcript Highlights:

• Um, the impact of the pharmaceutical restrictions is not hypothetical.
• > impact of the pharmaceutical impact of the pharmaceutical restrictions<00:25:35.919><c> is</c><00:25
• </c><00:29:24.720><c> companies</c> made by the pharmaceutical companies made by the pharmaceutical companies
• Goo or I don't pharmaceutical guys, Mr.
• </c> concerns that the pharmaceutical concerns that the pharmaceutical companies<00:30:59.360><c> have

Keywords: 912, senate, all

Summary: The committee heard testimony on HB 302, which would expand access to medical cannabis by removing the in-person provider-patient relationship requirement and related restrictions. The Department of Health supported the bill, and multiple advocates and organizations testified in support, including the ACLU of Hawaii, Hawaii Alliance for Cannabis Reform, Marijuana Policy Project, and others. Supporters said the measure would improve access for patients, especially on outer islands, and some urged broader amendments allowing providers to certify cannabis for any medical condition and to speed registration and treat in-state and out-of-state patients equally. No opposition was heard, and the bill was left with no questions after testimony. The committee also heard HB 1052 HD1, which clarifies that the Public Utilities Commission may use universal service fund monies to provide free telecommunications access for individuals with print disabilities. Testimony was uniformly supportive from the DCCA Division of Consumer Advocacy, the State Council on Developmental Disabilities, the Department of Human Services, the Public Utilities Commission, and the National Federation of the Blind of Hawaii. Witnesses described the program as an important accessibility service that has been operating under prior appropriations and should continue under the universal service program. HB 1482, relating to controlled substances and hemp/synthetic cannabinoids, drew support from the Department of Law Enforcement, Department of Health, Honolulu Police Department, and others, with some comments from the Attorney General’s office. Supporters said the bill would clarify that delta-8 THC is a controlled substance and help enforcement against illegal hemp products and synthetic cannabinoids. Testimony and questioning focused on the need for better lab testing capacity, retail registry and age-gating, seizure authority, nuisance abatement, and possible use of special funds or appropriations to support enforcement. Members also discussed enforcement of illegal hemp businesses and whether additional funding or statutory changes would be needed. Finally, the committee took up HB 712, a 340B drug-discount measure affecting safety-net providers and contract pharmacies. Hospitals, health centers, and provider groups testified in support, saying the bill would protect access to discounted drugs and preserve funding for services such as chronic disease management, transportation, and specialty care. Pharmaceutical-industry representatives opposed the bill or sought amendments, arguing the 340B program has expanded beyond its original intent and lacks transparency, and they requested reporting or audit-like provisions to verify claims and revenues. Members questioned both sides about alleged abuse, the growth of contract pharmacies, and whether the bill should include transparency requirements before moving forward.